These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8818128)

  • 1. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
    O'Brien B; Gafni A
    Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care contingent valuation studies: a review and classification of the literature.
    Diener A; O'Brien B; Gafni A
    Health Econ; 1998 Jun; 7(4):313-26. PubMed ID: 9683092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies.
    Currie GR; Donaldson C; O'Bbrien BJ; Stoddart GL; Torrance GW; Drummond MF
    Med Decis Making; 2002; 22(6):493-7. PubMed ID: 12458979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
    Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
    Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method.
    Tambor M; Pavlova M; Rechel B; Golinowska S; Sowada C; Groot W
    Soc Sci Med; 2014 Sep; 116():193-201. PubMed ID: 25016327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If the price is right: vagueness and values clarification in contingent valuation.
    Shiell A; Gold L
    Health Econ; 2003 Nov; 12(11):909-19. PubMed ID: 14601154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery.
    Dalmau-Matarrodona E
    Health Econ; 2001 Mar; 10(2):101-18. PubMed ID: 11252042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay for reductions in angina pectoris attacks.
    Kartman B; Andersson F; Johannesson M
    Med Decis Making; 1996; 16(3):248-53. PubMed ID: 8818123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care.
    O'Brien BJ; Goeree R; Gafni A; Torrance GW; Pauly MV; Erder H; Rusthoven J; Weeks J; Cahill M; LaMont B
    Med Care; 1998 Mar; 36(3):370-84. PubMed ID: 9520961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
    Smith RD
    Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of the contingent valuation market in health care: a critical assessment.
    Smith RD
    Health Econ; 2003 Aug; 12(8):609-28. PubMed ID: 12898660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuation of health changes with the contingent valuation method: a test of scope and question order effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1996; 5(6):531-41. PubMed ID: 9003940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of contingent valuation for health economics.
    Bayoumi AM
    Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contingent valuation method in health care.
    Klose T
    Health Policy; 1999 May; 47(2):97-123. PubMed ID: 10538292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The random card sort method and respondent certainty in contingent valuation: an exploratory investigation of range bias.
    Shackley P; Dixon S
    Health Econ; 2014 Oct; 23(10):1213-23. PubMed ID: 23922327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.
    Weimer DL; Vining AR; Thomas RK
    Health Econ; 2009 Feb; 18(2):181-202. PubMed ID: 18566968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual responsibility and health-risk behaviour: a contingent valuation study from the ex ante societal perspective.
    van der Star SM; van den Berg B
    Health Policy; 2011 Aug; 101(3):300-11. PubMed ID: 21168930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contingency of contingent valuation. How much are people willing to pay against Alzheimer's disease?
    Nocera S; Bonato D; Telser H
    Int J Health Care Finance Econ; 2002 Sep; 2(3):219-40. PubMed ID: 14625942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical implications of response acquiescence in discrete-choice contingent valuation.
    Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
    Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.